RYMO
Rymo Technologies is a Navi Mumbai-based medical device company founded in 2020 that develops US FDA Class II-cleared rehabilitation robotics (MOBI-L, MEND, NUDGE) for hospitals, rehabilitation centers, and physiotherapy clinics treating neurological, orthopedic, and post-surgical patients across India and select international markets.
- Company typePrivate
- Founded2020
- HeadquartersMumbai, India
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What RYMO does
Rymo Technologies Pvt. Ltd. is a Navi Mumbai, India-based medical device company founded in 2020 by Chirag Shah and Abhishek Rai that develops clinically validated, CDSCO-certified and US FDA Class II-cleared rehabilitation robotics for neurological, orthopedic, and physiotherapy applications. The company sells three core products: MOBI-L, a patented portable multi-limb robotic rehabilitation device combining assistive and resistive therapy with VR-based functional task training and real-time biofeedback; MEND, a digital balance board using visual and audio feedback for static and dynamic balance rehabilitation; and NUDGE, positioned as India's first light-based gamified system for cognitive training, reflex enhancement, and reaction time assessment. Underlying capabilities include 20+ exercises, 7+ joint protocols, 12+ gamified exercises with progressive challenge levels, and session-level quantitative data capture covering ROM, strength, speed, and reaction time, with EMR-ready automated reporting.
Rymo has deployed 452 devices across 354 clinical customers including AIIMS, Apollo Hospitals, and Manipal Hospitals, and supports a network of 328+ certified clinics across 45+ Indian cities, having enabled 50,000+ therapy sessions and treatment of 7,500+ patients. The revenue model is primarily hardware device sales to hospitals and rehabilitation centers, supplemented by flexible leasing options (with ROI claimed within 6-8 months) and recurring professional services including on-site staff certification, annual preventive maintenance, and a 24/7 technical helpdesk. Go-to-market combines direct enterprise field sales targeting hospital networks with a certified clinic channel program for mid-market physiotherapy accounts, plus a newly signed distribution partnership with Fourier Rehab for ASEAN market entry.
The company is venture-backed, having raised over Rs 10 crore (~USD 1.08 million) in a March 2026 seed round led by IAN Angel Fund with angel investor participation, and is supported by academic and innovation partnerships with IIT Bombay, IIT Madras, Social Alpha, BIRAC, NIDHI PRAYAS, GDC, and riidl. Regulatory posture is unusually strong for a seed-stage Indian medical device company, with US FDA Class II, ISO 13485:2016, IEC 60601-1, and CDSCO certifications in place, and stated intent to expand commercially into ASEAN and Middle East markets using the recent capital infusion.
RYMO firmographics
Firmographics- Name
- RYMO
- Legal name
- Rymo Technologies Pvt. Ltd.
- Website
- https://rymo.in
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Rymo Technologies is a Navi Mumbai-based medical device company founded in 2020 that develops US FDA Class II-cleared rehabilitation robotics (MOBI-L, MEND, NUDGE) for hospitals, rehabilitation centers, and physiotherapy clinics treating neurological, orthopedic, and post-surgical patients across India and select international markets.
- Ownership category
- akta.pro rank
RYMO industry classification
Industry- Product category
- Rehabilitation Robotics & Medical Devices
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)
- akta.pro secondary industries
- Digital Rehabilitation & Physical Therapy Therapeutics (HLACANAJ), Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS) (HSADAIAC), Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK)
Keywords
Where RYMO is headquartered
LocationHeadquarters
- HQ city
- Mumbai
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
RYMO business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Others
Revenue model
- Medical Device Hardware Sales: Sale of rehabilitation robotics devices (MOBI-L, MEND, NUDGE) to healthcare facilities including hospitals, clinics, and rehabilitation centers. One-time capital purchase model with device sales.
- Flexible Leasing Models: Flexible leasing options for healthcare facilities. Website mentions 'ROI within 06-08 months' indicating financing/lease options are available to lower upfront capital requirements for customers.
- Professional Services and Training: On-site staff certification, annual preventive maintenance, and 24/7 technical helpdesk services provided as part of device deployment and ongoing support.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Multi-year contract | Hardware device purchase model with flexible financing options |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
RYMO product offering
Product offeringCore offering
RYMO designs, manufactures, and sells clinically validated rehabilitation robotics devices — MOBI-L (portable multi-limb robotic rehab with VR therapy), MEND (digital balance board), and NUDGE (light-based cognitive/reflex training system) — for hospitals, rehabilitation centers, and physiotherapy clinics. The devices combine robotics, AI-driven adaptive resistance, real-time biofeedback, gamification, and EMR-ready data analytics to deliver high-intensity, measurable neuro-rehabilitation, orthopedic, oncology, and cardiac therapy. RYMO also provides flexible leasing, on-site staff certification, annual preventive maintenance, and 24/7 technical helpdesk as part of its deployment model.
Product overview
Rymo Technologies offers a portfolio of three clinically validated rehabilitation robotics products: MOBI-L (portable multi-limb robotic rehabilitation device), MEND (digital balance board), and NUDGE (light-based cognition and reflex training system). The products integrate robotics, virtual reality, and gamification to support neurological, orthopedic, and physiotherapy applications across healthcare facilities.
Differentiator
Problem solved
Functional benefit
Brands
- MOBI-L: Portable, Patented Multi-Limb Robotic Rehabilitation device for upper limb, lower limb, and ADL training with VR-based therapy.
- MEND
- NUDGE
Products and services
- MOBI-L Multi-Limb Robotic Rehabilitation System Portable, patented multi-limb robotic rehabilitation device for upper limb, lower limb, and ADL training, combining assistive, resistive, and VR-based therapy with 20+ exercises, 10+ attachments, 7+ joint protocols, real-time biofeedback, adaptive resistance, and 12+ gamified exercises. Designed for hospitals, rehabilitation centers, and physiotherapy clinics treating stroke, TBI, spinal cord injury, Parkinson's, and orthopedic conditions.
- MEND Digital Balance Board Portable digital balance trainer for static and dynamic balance rehabilitation, using multi-directional movement analysis, real-time visual and audio feedback, and gamified therapeutic interventions. Targets hospitals and clinics treating stroke, Parkinson's, fall-risk elderly, sports rehab, and orthopedic balance deficits.
- NUDGE Game-Based Cognition & Reflex Training System India's first light-based, wireless, subscription-free gamified system for cognitive training, reflex enhancement, agility, and reaction time assessment, with upper and lower limb motor engagement. Used by physiotherapy and neuro-rehabilitation clinics to improve brain-body coordination.
- Rymo Professional Services and Training On-site staff certification, annual preventive maintenance, and 24/7 technical helpdesk support provided to healthcare facilities purchasing MOBI-L, MEND, and NUDGE devices, supporting clinical adoption and ongoing uptime.
- Rymo Flexible Leasing Program Multi-year flexible leasing/financing option for MOBI-L, MEND, and NUDGE devices, lowering upfront capital outlay for hospitals and rehabilitation clinics with claimed ROI within 6-8 months.
Quantifiable outcome
- 85% improvement in patient adherence
- +7 more outcomes
Companies that use RYMO
Customer profileNamed customers8 records
Segments6 records
Ideal customer profiles3 records
RYMO technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature5 records
RYMO partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and supporting.
- Fourier RehabcoreDistribution partnership signed with Fourier Rehab for ASEAN market expansion. Supports Rymo's international scaling strategy beyond India into Southeast Asian markets.
- IIT BombaysupportingAcademic collaboration with IIT Bombay for research and development in rehabilitation technology
- IIT MadrassupportingAcademic collaboration with IIT Madras supporting research and development initiatives
- Social AlphasupportingAcademic and innovation partnership supporting technology development and market access
- BIRACsupportingGovernment-funded biotechnology and pharmaceutical research organization partnership supporting healthcare innovation
- NIDHI PRAYASsupportingStartup incubation program partnership supporting technology development and commercialization
- GDCsupportingAcademic institution partnership supporting rehabilitation technology research
- riidlsupportingInnovation and startup ecosystem partnership supporting technology commercialization
Scale indicators10 records
Recent moves5 records
Expansion highlights6 records
RYMO competitors and assessment
Company assessmentDirect peers
- Fourier Intelligence: China-based global leader in rehabilitation robotics offering upper-limb, lower-limb, and balance devices. Rymo's ASEAN distribution partnership with Fourier Rehab creates direct commercial overlap; product portfolios (multi-limb robotics + VR) are closely aligned.
- Ekso Bionics: US-listed developer of robotic exoskeletons for stroke and spinal cord injury rehabilitation. Comparable target customers (hospitals, rehab centers) and FDA-cleared Class II medical device regulatory positioning.
- Tyromotion: Austrian manufacturer of robotic and sensor-based therapy devices for upper extremity and balance rehabilitation. Closely comparable to MOBI-L and MEND in functionality and customer base.
- Hocoma (DIH): Swiss-origin global leader in robotic and sensor-based rehabilitation devices (Lokomat, Armeo). Competes head-to-head with MOBI-L in hospital neuro-rehab settings and sets the benchmark for clinical evidence and pricing.
- Bionik Laboratories: Robotic upper-limb rehabilitation devices for neurological patients. Direct overlap with Rymo's MOBI-L upper-limb therapy positioning and similar clinical evidence-led go-to-market.
- ReWalk Robotics: Developer of exoskeleton systems for spinal cord injury and stroke rehabilitation. Overlaps in neuro-rehab hospital channel and FDA Class II medical device category.
Emerging players
- Saebo: US-based developer of upper-limb rehabilitation devices and orthoses for stroke survivors. Comparable focus on neuro-rehab patient outcomes and therapist productivity, though primarily non-robotic devices.
- ABLE Human Motion: Spain-based startup developing robotic exoskeletons for gait rehabilitation in hospitals. Comparable stage and technology overlap with Rymo's lower-limb robotic rehab roadmap.
- Harmonic Bionics: US-based startup developing upper-extremity robotic rehabilitation devices. Similar product positioning to MOBI-L for stroke and neurological indications, comparable company stage.
Others
- Maxwell Healthcare Associates: Adjacent rehabilitation technology provider. Thematically related to rehab services but focused on healthcare consulting rather than robotic devices; included as ecosystem participant.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
RYMO social profiles
Digital presenceRYMO compliance and trust
Trust signalCompliance4 records
RYMO financial estimates
Financial estimateRevenue estimate
Valuation estimate
RYMO leadership team
Management profileNumber of profiles
Profiles2 records
RYMO funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RYMO M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RYMO
What does RYMO do?
RYMO designs, manufactures, and sells clinically validated rehabilitation robotics devices — MOBI-L (portable multi-limb robotic rehab with VR therapy), MEND (digital balance board), and NUDGE (light-based cognitive/reflex training system) — for hospitals, rehabilitation centers, and physiotherapy clinics. The devices combine robotics, AI-driven adaptive resistance, real-time biofeedback, gamification, and EMR-ready data analytics to deliver high-intensity, measurable neuro-rehabilitation, orthopedic, oncology, and cardiac therapy. RYMO also provides flexible leasing, on-site staff certification, annual preventive maintenance, and 24/7 technical helpdesk as part of its deployment model.
Is RYMO a public or private company?
RYMO is a private company. It is classified as venture growth investor backed and is currently operating.
When was RYMO founded?
RYMO was founded in 2020. It employs 11 to 50 people.
Where is RYMO based?
RYMO is headquartered in Mumbai, India, in the Asia region.
How does RYMO make money?
Three revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are flexible Leasing Models and professional Services and Training.
Who are RYMO's main competitors?
Direct peers on record are Fourier Intelligence, Ekso Bionics, Tyromotion, Hocoma (DIH), Bionik Laboratories and ReWalk Robotics. Emerging players are Saebo, ABLE Human Motion and Harmonic Bionics. Maxwell Healthcare Associates is listed as an others.
Does RYMO have an API?
No public API is recorded for RYMO.
What industry is RYMO in?
RYMO's product category is Rehabilitation Robotics & Medical Devices. Its primary akta.pro industry code is HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices), with a secondary code of HLACANAJ, Digital Rehabilitation & Physical Therapy Therapeutics. Its NAICS code is 5417 and its SIC code is 3845.